CHIMOVITS EREZ enters BRAVEHEART BIO, INC. with 1.10M shares plus derivative instruments
Holding both equity and derivatives at entry signals strong long-term conviction in the company.
Indirect Derivatives
Filed: 8/6/2026ACC: 0001470831-26-000775
Director10% Owner
Since Aug 2026
1.10M
Baseline shares
0.00
Direct ownership
0 positions
9.13M
Derivative underlying
1 instrument
1
Security positions
1.10M indirect
Non-Derivative Holdings1
Common Stock
IndirectShares owned1.10M
Total
1.10M indirect1.10M
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 1.10M | Indirect |
| Total | 1.10M | 1.10M indirect |
Derivative Holdings1
Series A Preferred Stock
IndirectUnderlying security
Common Stock
Underlying shares
9.13M
Shares owned
N/A
Exercise price
Expiration
—
Exercise window
—
Total
Underlying
9.13M
Owned
0.00
| Security | Underlying | Exercise Price | Exercise Window | Expiration | Underlying Shares | Shares Owned |
|---|---|---|---|---|---|---|
| Series A Preferred Stock Indirect | Common Stock | — | — | 9.13M | N/A | |
| Total | 9.13M | 0.00 | ||||